Wednesday, April 17

In February 2022, Medtronic (Ireland) received FDA approval for its InterStim X System, a next-generation personalized sacral nerve stimulation therapy for bladder and bowel control.Northbrook, IL 60062 — (SBWIRE) — 11/24/2022 — Neuromodulation Market is projected to reach USD 10.4 billion by 2027 from USD 6.0 billion in 2022…
Read More

Comments are closed.